Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease. Gruter T, Gaig C, Crijnen YS, Titulaer MJ, et al. JAMA Neurol 2025 Aug 4:e252574. doi: 10.1001/jamaneurol.2025.2574.

Read + Share

Amedeo Smart

Independent Medical Education

Gruter T, Gaig C, Crijnen YS, Titulaer MJ, et al. Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease. JAMA Neurol 2025 Aug 4:e252574. doi: 10.1001/jamaneurol.2025.2574.
PMID: 40758377